NCT06028776

Brief Summary

The goal of the present study is to evaluate the effects of a dance-based concept entitled MS Ballroom Fitness (developed in Denmark by PT Elisabeth Dalsgaard) in persons with multiple sclerosis (pwMS). A total of 88 pwMS will be enrolled and equally randomized into an intervention group or a control-waitlist group. Those in the intervention group will undertake 7 weeks of MS Ballroom Fitness, with 2 sessions per week. The investigators assume that balance, walking capacity as well as well-being will be improved.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
95

participants targeted

Target at P75+ for not_applicable multiple-sclerosis

Timeline
Completed

Started Jul 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2023

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

August 31, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 8, 2023

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 10, 2024

Completed
Last Updated

March 19, 2025

Status Verified

December 1, 2024

Enrollment Period

1 year

First QC Date

August 31, 2023

Last Update Submit

March 14, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Six spot step test (SSST)

    Objective test that measures walking coordination and balance. Unit: seconds.

    Change from Baseline to 7 weeks

  • WHO5 wellbeing index

    Questionnaire that measures current mental well-being. Unit: score (0-100; 100 is better).

    Change from Baseline to 7 weeks

Secondary Outcomes (12)

  • Static balance

    Change from Baseline to 7 weeks

  • Functional reach test

    Change from Baseline to 7 weeks

  • Modified functional reach test

    Change from Baseline to 7 weeks

  • Four square step test (FSST)

    Change from Baseline to 7 weeks

  • 6-minute walk test

    Change from Baseline to 7 weeks

  • +7 more secondary outcomes

Study Arms (2)

Intervention

EXPERIMENTAL

This group will be offered 2 weekly sessions (45-60 min) of MS Ballroom Fitness for a period of 7 weeks. All other 'usual care' are allowed.

Behavioral: MS Ballroom Fitness

Control

NO INTERVENTION

This group will continue their habitual living, also including whatever 'usual care' they participate in.

Interventions

A personalized dance-based concept focusing on balance, walking capacity, and well-being.

Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • self-reported MS diagnosis
  • patient-determined disease steps (PDDS) ≤ 7 (7 correspond to use a wheelchair for most daily activities)
  • able to independently attend the testing

You may not qualify if:

  • self-reported comorbidities excluding participation in the intervention
  • substantial cognitive impairments hindering participation
  • recent fractures (6 months)
  • critical physical impairments hindering participation in the described training study
  • participation in structured exercise therapy (including dancing) for the past 3 months (≥ 2 session per week of moderate-to-high intensity)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Aarhus University, Exercise Biology

Aarhus C, Jutland, 8000, Denmark

Location

MeSH Terms

Conditions

Multiple Sclerosis

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System Diseases

Study Officials

  • Lars Hvid, PhD

    University of Aarhus

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The investigators will use a classic RCT approach, although participants randomized into the control group will be offered the intervention afterwards (hence, termed control-waitlist group).
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 31, 2023

First Posted

September 8, 2023

Study Start

July 1, 2023

Primary Completion

June 30, 2024

Study Completion

September 10, 2024

Last Updated

March 19, 2025

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

By Danish Law and following GPDR regulations from Aarhus University, we are not allowed to share individual data.

Locations